To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene C6orf62TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
297 supporting clones for gene C6orf62 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
DA517000 brain .a 1 to 529 2 to 529   tiling clone, capped   528/528
(100 %)
4 diff
(99.3 %id)
DB092372 testis .a 3 to 555 2 to 554   tiling clone, capped   553/553
(100 %)
1 diff
(99.9 %id)
DA814206   .a 404 to 993 2 to 592   capped   591/591
(100 %)
4 diff
(99.4 %id)
BX482098   .a 406 to 1094 8 to 695       688/695
(98 %)
7 diff
(99.0 %id)
BP277543 Kidney .a 406 to 988 1 to 583       583/583
(100 %)
4 diff
(99.4 %id)
BM750656 Ascites, stomach .a 406 to 1001 1 to 596       596/596
(100 %)
2 diff
(99.7 %id)
AL136632 brain .a 407 to 2801 12 to 2405 exact available from DKFZ, AAA Possibly primed on the genome, locally A rich (25/28 A in genome downstream of last aligned base) 2394/2394
(100 %)
6 diff
(99.8 %id)
BM147734 leukopheresis .a 407 to 817 1 to 411   AAA   411/411
(100 %)
11 diff
(97.4 %id)
BP242578 Liver .a 408 to 994 1 to 588       588/588
(100 %)
3 diff
(99.5 %id)
AV709526 adrenal gland .a 412 to 818 407 to 1   AAA Submitted on the opposite strand 407/407
(100 %)
0 diff
(100 %id)
AV743612 cord Blood .a 412 to 877 463 to 19   AAA Submitted on the opposite strand 445/463
(96 %)
0 diff
(100 %id)
AA833812 germinal center B cell .a 413 to 683 1 to 271   AAA   271/271
(100 %)
0 diff
(100 %id)
BP275648 Kidney .a 413 to 995 1 to 584       584/584
(100 %)
1 diff
(99.9 %id)
BX474555   .a 414 to 1010 25 to 622       598/622
(96 %)
6 diff
(99.1 %id)
BM069876 Islets of Langerhans, Pancreas .a 418 to 675 258 to 1     Submitted on the opposite strand 258/258
(100 %)
0 diff
(100 %id)
BF109576 pooled .a 422 to 939 1 to 518   tiling clone, Submitted on the opposite strand 518/518
(100 %)
0 diff
(100 %id)
BF111215 carcinoid, lung .a 423 to 889 1 to 467     Submitted on the opposite strand 467/467
(100 %)
0 diff
(100 %id)
AU253761 neuroblastoma .a 423 to 1122 1 to 700     Submitted on the opposite strand 700/700
(100 %)
6 diff
(99.2 %id)
DA358429 subthalamic nucleus .a 425 to 971 2 to 548   capped   547/547
(100 %)
0 diff
(100 %id)
BE465032 carcinoid, lung .a 426 to 982 1 to 557     Submitted on the opposite strand 557/557
(100 %)
0 diff
(100 %id)
AB075502   .a 427 to 2807 8 to 2387 exact     2380/2380
(100 %)
3 diff
(99.9 %id)
AI458673 carcinoid, lung .a 427 to 931 1 to 505     Submitted on the opposite strand 505/505
(100 %)
0 diff
(100 %id)
NM_030939.4   .a 427 to 2876 21 to 2470 exact RefSeq, AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 2450/2450
(100 %)
0 diff
(100 %id)
BP297765   .a 436 to 1018 1 to 581       581/581
(100 %)
3 diff
(99.5 %id)
DA472138   .a 442 to 1156 2 to 718   capped   717/719
(99 %)
5 diff
(99.4 %id)
T11219   .a 449 to 649 1 to 201       201/201
(100 %)
0 diff
(100 %id)
BX345080 Neuroblastoma Cot 25-normalized .a 455 to 1350 1 to 889       889/908
(97 %)
17 diff
(98.2 %id)
BX403343 Neuroblastoma Cot 50-normalized .a 455 to 1311 1 to 858       858/859
(99 %)
18 diff
(98.0 %id)
AL529211 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized .a 457 to 1302 1 to 845       845/845
(100 %)
4 diff
(99.6 %id)
AV656408 corresponding non cancerous liver tissue .a 460 to 854 1 to 395     Submitted on the opposite strand 395/395
(100 %)
0 diff
(100 %id)
CN404002 embryonic stem cells, DMSO-treated H9 cellline .a 489 to 1103 1 to 615       615/615
(100 %)
3 diff
(99.6 %id)
BX953065   .a 505 to 936 1 to 432       432/432
(100 %)
0 diff
(100 %id)
BE908143 epithelioid carcinoma, Pancreas .a 508 to 1207 1 to 697       697/931
(74 %)
24 diff
(97.5 %id)
AA402388 ovarian tumor, ovary .a 520 to 1142 1 to 622       622/622
(100 %)
1 diff
(99.9 %id)
AK022681   .a 523 to 2874 1 to 2355 exact available from FLJ,   2355/2355
(100 %)
3 diff
(99.9 %id)
AU125496   .a 524 to 1383 2 to 865   capped   818/867
(94 %)
17 diff
(98.1 %id)
AV703346 adrenal gland .a 534 to 912 379 to 1     Submitted on the opposite strand 379/379
(100 %)
0 diff
(100 %id)
DB169619 kidney, tumor tissue .a 535 to 1096 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
DN989290 brain, whole brain .a 551 to 1299 9 to 757       749/757
(98 %)
7 diff
(99.1 %id)
BX505747   .a 595 to 1297 1 to 703       703/703
(100 %)
1 diff
(99.9 %id)
DB197138 trachea .a 599 to 1180 2 to 583   capped   582/582
(100 %)
1 diff
(99.9 %id)
BG030354 breast, mammary adenocarcinoma, cell line .a 623 to 1323 1 to 703       703/955
(73 %)
19 diff
(98.1 %id)
CN404001 embryonic stem cells, cell lines H1, H7, andH9 .a 642 to 1145 1 to 504       504/504
(100 %)
0 diff
(100 %id)
BX093169 senescent fibroblast .a 647 to 1341 1 to 695       695/696
(99 %)
1 diff
(99.9 %id)
BQ936991 epidermoid carcinoma, cell line, lung .a 653 to 1594 1 to 953       954/953
(100 %)
25 diff
(97.4 %id)
DA026837   .a 691 to 1266 2 to 577   capped   576/576
(100 %)
0 diff
(100 %id)
BC047866 Uterus, leiomyosarcoma .a 716 to 2801 1 to 2085 exact available from MGC, AAA Possibly primed on the genome, locally A rich (25/28 A in genome downstream of last aligned base) 2085/2085
(100 %)
2 diff
(100.0 %id)
BQ962629 leiomyosarcoma, uterus .a 717 to 1582 1 to 868       868/868
(100 %)
2 diff
(99.8 %id)
DA463305   .a 719 to 1275 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
DR158314 human embryonic stem cells differentiated toan early endodermal cell type .a 735 to 1527 1 to 793       793/793
(100 %)
0 diff
(100 %id)
DB029648 testis .a 748 to 1356 2 to 610   capped   609/609
(100 %)
0 diff
(100 %id)
DA601540   .a 752 to 1315 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
BG678705 skin, squamous cell carcinoma .a 753 to 1514 1 to 762       762/762
(100 %)
2 diff
(99.8 %id)
DA598188   .a 770 to 1330 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
AV708342 adrenal gland .a 784 to 1374 1 to 591       591/591
(100 %)
0 diff
(100 %id)
DA924862 small intestine .a 789 to 1372 2 to 586   capped   585/585
(100 %)
1 diff
(99.9 %id)
BP302413   .a 822 to 1403 1 to 582       582/582
(100 %)
4 diff
(99.4 %id)
BQ669513 epidermoid carcinoma, cell line, salivary gland .a 836 to 1756 1 to 924 R224P P225S     924/924
(100 %)
11 diff
(98.9 %id)
BU172545 melanotic melanoma, skin .a 865 to 1708 1 to 845 exact     845/845
(100 %)
2 diff
(99.8 %id)
BG167018 hypernephroma, cell line, Kidney .a 867 to 1651 1 to 777 A194V T195Q I196S F197S K198S ...     777/1081
(71 %)
28 diff
(97.5 %id)
AU138464 placenta .a 868 to 1536 2 to 673   capped   672/714
(94 %)
6 diff
(99.2 %id)
DA706916   .a 871 to 1435 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
DA695271   .a 872 to 1460 2 to 591   capped   590/590
(100 %)
1 diff
(99.9 %id)
BC040260 Brain, adult, 6 pooled whole brains .a 895 to 2876 1 to 1982 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 1982/1982
(100 %)
0 diff
(100 %id)
BI753721 brain .a 895 to 1768 1 to 875 K43N K44E K45E S47V A48S ... available from MGC,   875/878
(99 %)
23 diff
(97.4 %id)
TI_57219478   .a 895 to 1768 35 to 909 K43N K44E K45E S47V A48S ...     875/912
(95 %)
28 diff
(97.0 %id)
CB134546 Liver .a 906 to 1520 1 to 614       614/614
(100 %)
3 diff
(99.6 %id)
AY598792   .a 914 to 1603 1 to 690 exact     690/690
(100 %)
0 diff
(100 %id)
CR457292   .a 914 to 1602 1 to 689       689/690
(99 %)
2 diff
(99.8 %id)
CR533486   .a 914 to 1653 1 to 740 exact     740/740
(100 %)
0 diff
(100 %id)
BG717389 testis .a 936 to 1639 1 to 701       701/701
(100 %)
7 diff
(99.1 %id)
F11344 brain, total brain .a 941 to 1280 1 to 340       340/340
(100 %)
3 diff
(99.2 %id)
AU135776 placenta .a 954 to 1712 2 to 762   capped   761/763
(99 %)
8 diff
(99.0 %id)
BP203853 coronary artery .a 955 to 1530 1 to 576       576/576
(100 %)
0 diff
(100 %id)
BQ312441 breast_normal .a 957 to 1134 179 to 1       179/179
(100 %)
11 diff
(93.9 %id)
BP204587 coronary artery .a 957 to 1539 1 to 583       583/583
(100 %)
3 diff
(99.5 %id)
BP224847   .a 968 to 1549 1 to 581       581/581
(100 %)
2 diff
(99.7 %id)
DA695808   .a 970 to 1546 2 to 578   capped   577/577
(100 %)
0 diff
(100 %id)
DA695927   .a 970 to 1541 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
BE896141 melanotic melanoma, skin .a 976 to 1758 1 to 781       781/1180
(66 %)
33 diff
(97.3 %id)
BG035327 adenocarcinoma, cell line, Liver .a 980 to 1689 1 to 704       704/805
(87 %)
11 diff
(98.7 %id)
DB059590 testis .a 1007 to 1545 2 to 540   capped   539/539
(100 %)
0 diff
(100 %id)
CU447592 epidermis .a 1021 to 1777 774 to 16     Submitted on the opposite strand 759/774
(98 %)
0 diff
(100 %id)
DB018791 esophageal, tumor tissue .a 1031 to 1619 2 to 590   capped   589/589
(100 %)
0 diff
(100 %id)
BQ936611 epidermoid carcinoma, cell line, lung .a 1075 to 2025 1 to 954       954/955
(99 %)
13 diff
(98.7 %id)
BQ213412 embryonal carcinoma, cell line, testis .a 1222 to 2077 1 to 856       856/856
(100 %)
2 diff
(99.8 %id)
BE785982 large cell carcinoma, lung .a 1227 to 1976 1 to 748       748/748
(100 %)
21 diff
(97.2 %id)
AJ420475   .a 1236 to 2857 9 to 1630   AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 1622/1630
(99 %)
8 diff
(99.6 %id)
BM543590 brain, hippocampus .a 1253 to 2118 24 to 899       876/957
(91 %)
21 diff
(97.9 %id)
BM693534 eye, Retina Foveal and Macular .a 1269 to 1770 1 to 502       502/502
(100 %)
0 diff
(100 %id)
BP376487 uterus .a 1288 to 1870 1 to 581       581/581
(100 %)
4 diff
(99.4 %id)
CB112802 Liver .a 1292 to 1964 1 to 672       672/672
(100 %)
1 diff
(99.9 %id)
BU161341 melanotic melanoma, skin .a 1297 to 2139 1 to 857       857/879
(97 %)
24 diff
(97.3 %id)
TI_154176343   .a 1297 to 1869 80 to 659       580/1114
(52 %)
10 diff
(99.2 %id)
TI_154176439   .a 1297 to 2080 80 to 870       791/1085
(72 %)
45 diff
(95.9 %id)
CA311751 Human Lung Epithelial cells, lung .a 1316 to 1914 617 to 19   AAA   599/599
(100 %)
0 diff
(100 %id)
CB853612 Human Lung Epithelial cells, lung .a 1316 to 1928 631 to 19   AAA   613/613
(100 %)
0 diff
(100 %id)
BX328997 Neuroblastoma Cot 50-normalized .a 1341 to 2051 710 to 1       710/710
(100 %)
13 diff
(98.2 %id)
TI_149291731   .a 1345 to 2037 766 to 80   AAA   687/715
(96 %)
12 diff
(98.4 %id)
AL601897   .a 1351 to 2055 1 to 706       706/706
(100 %)
3 diff
(99.6 %id)
CD521642 pooled .a 1362 to 2049 1 to 696       696/824
(84 %)
23 diff
(97.3 %id)
CA431111 cell lines, Chondrosarcoma .a 1366 to 2106 759 to 19   AAA Possibly primed on the genome, locally A rich (11/12 A in genome downstream of last aligned base) 741/741
(100 %)
1 diff
(99.9 %id)
CB115812 Liver .a 1380 to 1898 1 to 519       519/519
(100 %)
0 diff
(100 %id)
BM721238 eye, fetal eye .a 1406 to 2145 1 to 739   fully sequenced, Possibly primed on the genome, locally A rich (25/28 A in genome downstream of last aligned base) 739/739
(100 %)
7 diff
(99.1 %id)
BU682152 lung .a 1414 to 2037 635 to 13   AAA   623/624
(99 %)
6 diff
(99.1 %id)
BI856689 breast, mammary adenocarcinoma, cell line .a 1420 to 2294 1 to 878       878/878
(100 %)
30 diff
(96.6 %id)
TI_57188646   .a 1420 to 2294 56 to 933       878/878
(100 %)
30 diff
(96.6 %id)
BP263935 small intestine .a 1424 to 2004 1 to 581       581/581
(100 %)
0 diff
(100 %id)
BU625429 cell lines, Enchondroma .a 1461 to 2106 664 to 19   AAA Possibly primed on the genome, locally A rich (11/12 A in genome downstream of last aligned base) 646/656
(98 %)
4 diff
(99.4 %id)
BF342003 brain, glioblastoma with EGFR amplification .a 1464 to 2255 1 to 794       794/1017
(78 %)
22 diff
(97.9 %id)
BY996479   .a 1475 to 2165 21 to 711       691/711
(97 %)
6 diff
(99.2 %id)
BE895824 melanotic melanoma, skin .a 1476 to 2014 1 to 539       539/539
(100 %)
0 diff
(100 %id)
BP206361 coronary artery .a 1509 to 2090 1 to 582       582/582
(100 %)
0 diff
(100 %id)
BQ428034 leiomyosarcoma, uterus .a 1558 to 2406 1 to 853       853/855
(99 %)
14 diff
(98.4 %id)
BG249958 adenocarcinoma, cell line, Liver .a 1594 to 2319 1 to 724       724/1035
(69 %)
20 diff
(98.1 %id)
BU930801 Prostate .a 1608 to 2372 1 to 769       769/774
(99 %)
13 diff
(98.4 %id)
BX479627   .a 1622 to 2230 1 to 609       609/609
(100 %)
0 diff
(100 %id)
BM467855 leiomyosarcoma, uterus .a 1646 to 2647 1 to 1010       1010/1087
(92 %)
25 diff
(97.8 %id)
AA554017 colon, tumor .a 1667 to 2004 1 to 338     Submitted on the opposite strand 338/338
(100 %)
0 diff
(100 %id)
BQ434599 leiomyosarcoma, uterus .a 1673 to 2548 1 to 878       878/880
(99 %)
7 diff
(99.3 %id)
CB265784 adipose .a 1688 to 2318 1 to 632       632/634
(99 %)
4 diff
(99.4 %id)
TI_57153018   .a 1693 to 2382 33 to 721       689/723
(95 %)
19 diff
(97.4 %id)
CN389512 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 1697 to 2385 1 to 690       690/690
(100 %)
3 diff
(99.6 %id)
BQ050853 leiomyosarcoma, uterus .a 1704 to 2553 1 to 856       856/1050
(81 %)
28 diff
(97.4 %id)
BP243264 Liver .a 1706 to 2280 1 to 574       574/574
(100 %)
4 diff
(99.4 %id)
CN389511 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 1732 to 2389 1 to 658       658/658
(100 %)
0 diff
(100 %id)
AU117591 whole embryo, mainly head .a 1750 to 2504 2 to 756   capped   755/755
(100 %)
1 diff
(99.9 %id)
BG260386 bladder, transitional cell papilloma, cell line .a 1786 to 2539 1 to 747       747/842
(88 %)
22 diff
(97.4 %id)
CN389513 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 1846 to 2532 1 to 687       687/687
(100 %)
0 diff
(100 %id)
CB110902 Liver .a 1885 to 2106 1 to 222   AAA Possibly primed on the genome, locally A rich (11/12 A in genome downstream of last aligned base) 222/222
(100 %)
0 diff
(100 %id)
BP207109 coronary artery .a 1893 to 2474 1 to 583       583/583
(100 %)
5 diff
(99.2 %id)
AU119873 whole embryo, mainly head .a 1900 to 2673 2 to 771   capped   770/776
(99 %)
9 diff
(98.9 %id)
AL563388 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized .a 1903 to 2762 859 to 1       859/859
(100 %)
8 diff
(99.1 %id)
BU934089 mixed (pool of 40 RNAs) .a 1932 to 2671 1 to 760       760/836
(90 %)
30 diff
(96.5 %id)
BU852140 testis .a 1941 to 2736 1 to 808       808/812
(99 %)
30 diff
(96.4 %id)
BU854234 testis .a 1941 to 2691 1 to 758       758/778
(97 %)
25 diff
(96.8 %id)
FN156633 breast carcinoma .a 1948 to 2031 9 to 91   AAA   83/91
(91 %)
1 diff
(99.0 %id)
BF244691 brain, glioblastoma .a 1952 to 2376 1 to 454       454/454
(100 %)
31 diff
(93.2 %id)
FN141867 breast carcinoma .a 1970 to 2073 1 to 101       101/101
(100 %)
4 diff
(96.1 %id)
TI_149272590   .a 2029 to 2833 869 to 65       805/1118
(72 %)
0 diff
(100 %id)
TI_154128564   .a 2065 to 2801 823 to 87   AAA Possibly primed on the genome, locally A rich (25/28 A in genome downstream of last aligned base) 737/738
(99 %)
4 diff
(99.5 %id)
AA370915 Prostate .a 2080 to 2315 1 to 236       236/236
(100 %)
0 diff
(100 %id)
TI_154023828   .a 2087 to 2834 811 to 61       751/811
(92 %)
0 diff
(100 %id)
AA426578 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 2120 to 2520 1 to 400   fully sequenced,   400/400
(100 %)
1 diff
(99.8 %id)
BQ010321 Chondrosarcoma, Left Pubic Bone .a 2122 to 2801 697 to 19   AAA Possibly primed on the genome, locally A rich (25/28 A in genome downstream of last aligned base) 679/679
(100 %)
1 diff
(99.9 %id)
BM692651 eye, Retina Foveal and Macular .a 2129 to 2712 1 to 584       584/589
(99 %)
3 diff
(99.5 %id)
BU675186 lung, Primary Lung Epithelial Cells .a 2132 to 2818 687 to 2       686/687
(99 %)
0 diff
(100 %id)
BM679652 eye, fetal eye .a 2143 to 2801 678 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (25/28 A in genome downstream of last aligned base) 660/660
(100 %)
1 diff
(99.9 %id)
CA417629 Chondrosarcoma Cell line .a 2148 to 2801 673 to 19   AAA Possibly primed on the genome, locally A rich (25/28 A in genome downstream of last aligned base) 655/655
(100 %)
1 diff
(99.9 %id)
CA314456 Human Lung Epithelial cells, lung .a 2166 to 2801 654 to 19   AAA Possibly primed on the genome, locally A rich (25/28 A in genome downstream of last aligned base) 636/645
(98 %)
1 diff
(99.9 %id)
BU733961 eye, Retina Foveal and Macular .a 2186 to 2801 635 to 19   AAA Possibly primed on the genome, locally A rich (25/28 A in genome downstream of last aligned base) 617/617
(100 %)
4 diff
(99.4 %id)
CA415282 Chondrosarcoma Grade II, Left Pelvis .a 2192 to 2876 705 to 19   AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 687/687
(100 %)
1 diff
(99.9 %id)
BX483096   .a 2196 to 2796 1 to 600       600/600
(100 %)
2 diff
(99.7 %id)
FN100338 breast carcinoma .a 2210 to 2307 1 to 92       92/92
(100 %)
4 diff
(95.7 %id)
AI299975 carcinoid, lung .a 2235 to 2657 1 to 423     Submitted on the opposite strand 423/423
(100 %)
0 diff
(100 %id)
BM999898 Fibrosarcoma .a 2237 to 2981 757 to 13   tiling clone, AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 745/745
(100 %)
0 diff
(100 %id)
CD521540 pooled .a 2302 to 2874 1 to 573       573/574
(99 %)
2 diff
(99.7 %id)
AA669103 germinal center B cell .a 2328 to 2810 483 to 1       483/483
(100 %)
0 diff
(100 %id)
AU149143   .a 2331 to 2874 543 to 1       543/543
(100 %)
10 diff
(98.2 %id)
DB316907 brain .a 2342 to 2874 537 to 3       535/539
(99 %)
0 diff
(100 %id)
AW189346 serous papillary carcinoma, high grade, 2pooled tumors, uterus .a 2345 to 2458 142 to 29   AAA Possibly primed on the genome, locally A rich (11/12 A in genome downstream of last aligned base) 114/114
(100 %)
6 diff
(94.8 %id)
AA974142 pooled germ cell tumors .a 2378 to 2801 424 to 1       424/424
(100 %)
0 diff
(100 %id)
BX345079 Neuroblastoma Cot 25-normalized .a 2382 to 2742 389 to 28       362/389
(93 %)
0 diff
(100 %id)
AW152140 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .a 2390 to 2874 485 to 1       485/485
(100 %)
0 diff
(100 %id)
DB522134 testis .a 2402 to 2876 1 to 480     Submitted on the opposite strand 480/480
(100 %)
3 diff
(99.4 %id)
N50863 multiple sclerosis lesions .a 2418 to 2876 459 to 1       459/460
(99 %)
0 diff
(100 %id)
AU156276 placenta .a 2418 to 2801 383 to 1       383/383
(100 %)
1 diff
(99.8 %id)
AU157623 placenta .a 2418 to 2876 460 to 1       460/463
(99 %)
6 diff
(98.8 %id)
DB523181 testis .a 2420 to 2874 1 to 458     Submitted on the opposite strand 458/458
(100 %)
2 diff
(99.6 %id)
BU753090 placenta .a 2425 to 2876 467 to 16   AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 452/452
(100 %)
0 diff
(100 %id)
TI_154038827   .a 2426 to 2876 524 to 74   AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 451/807
(55 %)
8 diff
(99.1 %id)
BM665330 eye, Retina Foveal and Macular .a 2432 to 2801 387 to 19   AAA Possibly primed on the genome, locally A rich (25/28 A in genome downstream of last aligned base) 369/369
(100 %)
1 diff
(99.8 %id)
FN155467 breast carcinoma .a 2449 to 2587 1 to 138       138/138
(100 %)
3 diff
(97.9 %id)
TI_149308648   .a 2456 to 2682 293 to 67       905/1057
(85 %)
35 diff
(96.7 %id)
AA830534 germinal center B cell .a 2461 to 2801 353 to 13   AAA Possibly primed on the genome, locally A rich (25/28 A in genome downstream of last aligned base) 341/341
(100 %)
0 diff
(100 %id)
AA744833 germinal center B cell .a 2463 to 2801 353 to 15   AAA Possibly primed on the genome, locally A rich (25/28 A in genome downstream of last aligned base) 339/339
(100 %)
0 diff
(100 %id)
AA418914 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 2490 to 2801 311 to 1   fully sequenced,   311/311
(100 %)
1 diff
(99.7 %id)
F09004 brain, total brain .a 2519 to 2801 284 to 1       284/284
(100 %)
1 diff
(99.7 %id)
BE349314 malignant melanoma, metastatic to lymphnode, skin .a 2536 to 2802 267 to 1       267/267
(100 %)
0 diff
(100 %id)
FN092907 breast carcinoma .a 2577 to 2645 1 to 70       70/77
(90 %)
2 diff
(97.5 %id)
AA844611 parathyroid gland, parathyroid tumor .a 2650 to 2807 158 to 1       158/158
(100 %)
0 diff
(100 %id)
FN161317 breast carcinoma .a 2663 to 2784 1 to 119       119/119
(100 %)
3 diff
(97.5 %id)
D20450   .a 2731 to 2978 1 to 248     Submitted on the opposite strand 248/248
(100 %)
0 diff
(100 %id)
BU564319 mixed (pool of 40 RNAs) .a 2733 to 2801 1 to 69   AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 69/70
(98 %)
2 diff
(97.2 %id)
TI_149280161   .a 2938 to 3635 774 to 78   tiling clone, AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 697/697
(100 %)
6 diff
(99.2 %id)
BU679012 lung, Primary Lung Epithelial Cells .a 2960 to 3635 693 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 675/675
(100 %)
2 diff
(99.8 %id)
AA481714 ovarian tumor, ovary .a 3045 to 3347 1 to 303   fully sequenced,   303/303
(100 %)
1 diff
(99.7 %id)
AA481476 ovarian tumor, ovary .a 3317 to 3635 320 to 1   tiling clone, fully sequenced,   320/320
(100 %)
0 diff
(100 %id)
DB329800 Prostate .a 3384 to 3964 1 to 590     Submitted on the opposite strand 590/592
(99 %)
20 diff
(96.7 %id)
AI539468 pooled .a 3571 to 4130 560 to 1       560/560
(100 %)
2 diff
(99.7 %id)
AA917428 pooled .a 3623 to 4025 403 to 1   tiling clone,   403/403
(100 %)
0 diff
(100 %id)
AA527569 colon .a 3638 to 4225 1 to 588   tiling clone, Submitted on the opposite strand 588/588
(100 %)
6 diff
(99.0 %id)
DA865158 placenta .a 3718 to 4286 2 to 568   tiling clone, capped   567/567
(100 %)
1 diff
(99.9 %id)
AA252853.
matches multiple genes
germinal center B cell .a 4260 to 4413 1 to 154   tiling clone, also hits gene TFRC 154/154
(100 %)
0 diff
(100 %id)
DA878386 Prostate .b 1 to 571 2 to 572   tiling clone, capped   571/571
(100 %)
1 diff
(99.9 %id)
DA188011 amygdala .b 75 to 619 2 to 546   capped   545/545
(100 %)
0 diff
(100 %id)
DB164772 thymus .b 87 to 674 2 to 589   capped   588/588
(100 %)
3 diff
(99.5 %id)
DA387662 thalamus .b 89 to 631 2 to 544   tiling clone, capped   543/543
(100 %)
0 diff
(100 %id)
DB123688 thymus .b 89 to 725 2 to 638   capped   637/637
(100 %)
1 diff
(99.9 %id)
DB154362 thymus .b 90 to 631 2 to 543   capped   542/542
(100 %)
0 diff
(100 %id)
CR982018 T-Lymphocytes .b 109 to 616 1 to 508       508/512
(99 %)
1 diff
(99.9 %id)
BG655426 Pancreas, Purified pancreatic islet .b 126 to 580 1 to 455       455/455
(100 %)
0 diff
(100 %id)
AI807413 pooled .b 420 to 787 1 to 368     Submitted on the opposite strand 368/368
(100 %)
0 diff
(100 %id)
DA386342 thalamus .b 534 to 1121 2 to 589   tiling clone, capped   588/588
(100 %)
2 diff
(99.7 %id)
TI_57217369   .b 574 to 1056 58 to 533       476/533
(89 %)
6 diff
(98.9 %id)
BI754669 brain .b 579 to 1056 1 to 471   tiling clone,   471/471
(100 %)
14 diff
(97.1 %id)
BP377232 uterus .b 1090 to 1663 1 to 571 D3G K8R K9N Q10S A11S ... tiling clone,   571/571
(100 %)
5 diff
(99.2 %id)
DB457691 testis .c 1 to 470 1 to 470   tiling clone,   470/470
(100 %)
1 diff
(99.8 %id)
AW063931 thymus .c 200 to 640 440 to 1   tiling clone, Submitted on the opposite strand 440/440
(100 %)
1 diff
(99.8 %id)
DW410430 Liver .c 311 to 618 17 to 324       308/334
(92 %)
8 diff
(97.7 %id)
BE813002 amnion_normal .c 368 to 684 1 to 318       318/322
(98 %)
4 diff
(98.8 %id)
BF207643 bladder, carcinoma, cell line .c 386 to 912 1 to 525   tiling clone,   525/534
(98 %)
8 diff
(98.6 %id)
BF029248 bladder, carcinoma, cell line .c 404 to 939 1 to 536       536/673
(79 %)
26 diff
(96.2 %id)
CB145314 Liver .c 426 to 876 451 to 1     Submitted on the opposite strand 451/451
(100 %)
1 diff
(99.8 %id)
CD368613 Alveolar Macrophage, lung .c 651 to 1259 625 to 15   tiling clone, AAA   611/611
(100 %)
1 diff
(99.9 %id)
AA886088 metastatic prostate bone lesion .c 871 to 1173 9 to 311       303/311
(97 %)
6 diff
(98.1 %id)
BX497894 Liver .c 943 to 1434 1 to 493       493/493
(100 %)
2 diff
(99.6 %id)
AA298121   .c 961 to 1259 300 to 2       299/300
(99 %)
0 diff
(100 %id)
AW972292   .c 961 to 1271 446 to 136     Submitted on the opposite strand 311/546
(56 %)
6 diff
(99.0 %id)
AA516048 liposarcoma .c 961 to 1274 376 to 63       314/385
(81 %)
0 diff
(100 %id)
AA385848 Pancreas .c 1002 to 1317 1 to 317       317/317
(100 %)
1 diff
(99.7 %id)
C01428   .c 1050 to 1259 1 to 210       210/210
(100 %)
0 diff
(100 %id)
AW089273 brain, tumor, 5 pooled (see description) .c 1095 to 1259 183 to 19   AAA   165/165
(100 %)
0 diff
(100 %id)
DA426118 colon .c 1121 to 1685 2 to 566   tiling clone, capped   565/565
(100 %)
0 diff
(100 %id)
BM193754 leukopheresis .c 1129 to 1260 148 to 17   AAA   132/132
(100 %)
7 diff
(94.7 %id)
BX295245   .d 1 to 149 156 to 1   tiling clone,   156/163
(95 %)
13 diff
(92.1 %id)
BX295246   .d 1 to 186 193 to 8   tiling clone,   186/200
(93 %)
3 diff
(98.5 %id)
FN147575 breast carcinoma .d 17 to 108 1 to 89       89/90
(98 %)
2 diff
(97.8 %id)
FN153255 breast carcinoma .d 17 to 108 1 to 92       92/93
(98 %)
1 diff
(99.0 %id)
BX295254   .d 26 to 217 1 to 192   tiling clone,   192/216
(88 %)
10 diff
(95.4 %id)
BX295255   .d 27 to 217 1 to 194       194/218
(88 %)
12 diff
(94.5 %id)
BF748822 breast_normal .d 173 to 549 380 to 1   tiling clone, Submitted on the opposite strand 380/380
(100 %)
14 diff
(96.4 %id)
BM146680 leukopheresis .d 391 to 793 1 to 404   tiling clone,   404/404
(100 %)
7 diff
(98.3 %id)
CX787588 human embryonic stem cells .e 1 to 821 1 to 821 exact tiling clone,   821/821
(100 %)
0 diff
(100 %id)
AK301718 testis .f 1 to 948 2 to 949 exact tiling clone,   949/949
(100 %)
0 diff
(100 %id)
DC394708 testis .f 1 to 550 2 to 552       552/552
(100 %)
2 diff
(99.7 %id)
BP205367 coronary artery .f 175 to 748 1 to 573 R14Q     573/573
(100 %)
2 diff
(99.7 %id)
BP261861 small intestine .f 220 to 801 1 to 582 I56V F121V     582/582
(100 %)
2 diff
(99.7 %id)
CN404003 embryonic stem cells, DMSO-treated H9 cellline .f 238 to 847 1 to 612       612/612
(100 %)
3 diff
(99.6 %id)
BP289885 lung .f 241 to 825 1 to 584       584/584
(100 %)
4 diff
(99.4 %id)
DA601972   .f 247 to 799 2 to 554   capped   553/553
(100 %)
0 diff
(100 %id)
FN148354 breast carcinoma .f 249 to 345 97 to 1     Submitted on the opposite strand 97/97
(100 %)
0 diff
(100 %id)
BP267496 thyroid .f 252 to 832 1 to 581       581/581
(100 %)
0 diff
(100 %id)
BP267984 thyroid .f 252 to 828 1 to 578       578/578
(100 %)
1 diff
(99.9 %id)
BE178693 head_neck .f 284 to 389 1 to 106       106/106
(100 %)
0 diff
(100 %id)
BE829355 lung_tumor .f 284 to 528 1 to 245       245/245
(100 %)
0 diff
(100 %id)
BP207436 coronary artery .f 305 to 885 1 to 582       582/582
(100 %)
2 diff
(99.7 %id)
CU450559 epidermis .f 336 to 909 591 to 16     Submitted on the opposite strand 576/591
(97 %)
0 diff
(100 %id)
DB044245 testis .f 348 to 896 2 to 550   capped   549/549
(100 %)
0 diff
(100 %id)
FN105447 breast carcinoma .f 475 to 542 68 to 1     Submitted on the opposite strand 68/73
(93 %)
0 diff
(100 %id)
AW382097 head_neck .f 632 to 838 7 to 210       204/210
(97 %)
6 diff
(97.2 %id)
DA831254 placenta .f 845 to 1498 2 to 650   tiling clone, capped   649/698
(92 %)
14 diff
(98.0 %id)
DB376825 placenta .f 2185 to 2648 464 to 1   tiling clone,   464/467
(99 %)
5 diff
(99.0 %id)
DA877875 Prostate .g 1 to 574 2 to 575   tiling clone, capped   574/574
(100 %)
0 diff
(100 %id)
DA468066   .g 76 to 595 2 to 531   capped   530/535
(99 %)
9 diff
(98.4 %id)
ES315739 melanoma cell line .g 179 to 664 528 to 42   tiling clone, Submitted on the opposite strand 487/528
(92 %)
0 diff
(100 %id)
BF891265 marrow .g 199 to 564 366 to 1     Submitted on the opposite strand 366/369
(99 %)
10 diff
(97.3 %id)
AA333225 Embryo, 8 weeks .g 533 to 862 1 to 336       336/340
(98 %)
9 diff
(97.4 %id)
BI020708 marrow .g 576 to 929 1 to 354       354/354
(100 %)
0 diff
(100 %id)
CR984682 T-Lymphocytes .g 612 to 1337 1 to 727   tiling clone,   727/727
(100 %)
1 diff
(99.9 %id)
BM839368 Ascites, stomach .g 721 to 1233 1 to 513       513/513
(100 %)
1 diff
(99.9 %id)
BE937087 stomach_normal .g 723 to 1140 1 to 420       420/421
(99 %)
24 diff
(94.3 %id)
BE159342 head_neck .g 863 to 1103 242 to 3     Submitted on the opposite strand 240/242
(99 %)
0 diff
(100 %id)
BM545473 brain, hippocampus .g 1041 to 1792 1 to 760   tiling clone,   760/1039
(73 %)
11 diff
(99.0 %id)
BG677384 skin, squamous cell carcinoma .g 1060 to 1754 1 to 696   tiling clone,   696/873
(79 %)
8 diff
(99.1 %id)
BY795513 eye .g 1093 to 1684 1 to 592       592/592
(100 %)
0 diff
(100 %id)
DB330216 Prostate .g 2095 to 2630 538 to 3 exact tiling clone,   536/538
(99 %)
0 diff
(100 %id)
CV333784 nervous_tumor .h-u 1 to 451 1 to 451   tiling clone,   451/473
(95 %)
4 diff
(99.2 %id)
BE543742 cervical carcinoma cell line, cervix .h-u 177 to 581 406 to 1   tiling clone, Submitted on the opposite strand 406/409
(99 %)
2 diff
(99.6 %id)
T99698 liver and spleen .h-u 178 to 488 1 to 317   tiling clone,   317/318
(99 %)
7 diff
(97.8 %id)
AW876848 pnet .h-u 464 to 1055 1 to 595   tiling clone,   595/603
(98 %)
23 diff
(96.2 %id)
DA812654 ovary, tumor tissue .h-u 698 to 1429 2 to 737 R23T tiling clone, capped   736/811
(90 %)
11 diff
(98.7 %id)
BF846912 lung_normal .h-u 794 to 1011 1 to 217   tiling clone,   217/217
(100 %)
3 diff
(98.7 %id)
R01357 liver and spleen .h-u 1028 to 1294 1 to 276   fully sequenced,   276/276
(100 %)
14 diff
(95.0 %id)
R01243 liver and spleen .h-u 1279 to 1688 421 to 3   tiling clone, fully sequenced,   419/421
(99 %)
0 diff
(100 %id)
AU155408 ovary, tumor tissue .h-u 2022 to 2464 440 to 1   tiling clone,   440/451
(97 %)
4 diff
(99.2 %id)
DB480969 hippocampus .i-u 1 to 474 1 to 474   tiling clone,   474/474
(100 %)
0 diff
(100 %id)
CV574014 cornea, eye .i-u 17 to 633 1 to 618       618/618
(100 %)
3 diff
(99.6 %id)
TI_154149906   .i-u 17 to 520 80 to 582       503/505
(99 %)
17 diff
(96.7 %id)
BG116557 duodenal adenocarcinoma, cell line, small intestine .i-u 34 to 775 1 to 739 P41R V42Y Y43T T44L V45*     739/816
(90 %)
11 diff
(98.7 %id)
CB151550 cervix, Uterine .i-u 39 to 601 1 to 563       563/563
(100 %)
1 diff
(99.9 %id)
DA510583 brain .i-u 122 to 701 2 to 581   tiling clone, capped   580/580
(100 %)
1 diff
(99.9 %id)
BF765346 colon_est .i-u 428 to 567 143 to 5     Submitted on the opposite strand 139/149
(93 %)
0 diff
(100 %id)
CU443895 epidermis .i-u 448 to 605 1 to 159       159/166
(95 %)
8 diff
(95.2 %id)
CU444463 epidermis .i-u 448 to 605 1 to 159       159/166
(95 %)
8 diff
(95.2 %id)
CU445810 epidermis .i-u 448 to 605 1 to 159       159/166
(95 %)
9 diff
(94.6 %id)
CU447487 epidermis .i-u 448 to 605 1 to 159       159/166
(95 %)
8 diff
(95.2 %id)
CU454639 epidermis .i-u 448 to 605 1 to 158       158/184
(85 %)
10 diff
(94.6 %id)
DA391794 thalamus .i-u 674 to 1248 2 to 576   tiling clone, capped   575/575
(100 %)
0 diff
(100 %id)
BQ951468 leiomyosarcoma, uterus .i-u 682 to 1404 61 to 781   AAA   721/781
(92 %)
6 diff
(99.3 %id)
BF326045 amnion_normal .i-u 688 to 832 1 to 144       144/144
(100 %)
5 diff
(96.6 %id)
BM751717 Ascites, stomach .i-u 690 to 1225 1 to 535       535/535
(100 %)
1 diff
(99.9 %id)
BF326041 amnion_normal .i-u 697 to 832 1 to 135       135/135
(100 %)
4 diff
(97.1 %id)
BF326042 amnion_normal .i-u 698 to 832 1 to 136       136/136
(100 %)
5 diff
(96.4 %id)
BF326037 amnion_normal .i-u 699 to 832 1 to 134       134/134
(100 %)
1 diff
(99.3 %id)
BQ217432 melanotic melanoma, skin .i-u 721 to 1477 1 to 757   tiling clone,   757/851
(88 %)
16 diff
(98.2 %id)
BM016286 breast, mammary adenocarcinoma, cell line .i-u 756 to 1370 1 to 641       641/641
(100 %)
75 diff
(88.3 %id)
BM786043 Ascites, stomach .i-u 761 to 1364 1 to 603       603/603
(100 %)
1 diff
(99.9 %id)
DA042159 bladder .i-u 824 to 1333 2 to 513   capped   512/512
(100 %)
5 diff
(99.1 %id)
BG252842 adenocarcinoma, cell line, Liver .i-u 830 to 1474 670 to 24   tiling clone, Submitted on the opposite strand 647/692
(93 %)
0 diff
(100 %id)
DA542677   .i-u 835 to 1470 2 to 637   tiling clone, capped, AAA   636/636
(100 %)
4 diff
(99.4 %id)
BX643982   .j 1 to 775 1 to 773 exact tiling clone,   773/773
(100 %)
10 diff
(98.8 %id)
DB456707 testis .j 729 to 1221 1 to 493   tiling clone,   493/493
(100 %)
0 diff
(100 %id)
DB303925 brain Gene C6orf62, variant not shown              
DA199425 brain Gene C6orf62, variant not shown       capped      
DA232832 brain Gene C6orf62, variant not shown       capped      
DB314227 tongue, tumor tissue Gene C6orf62, variant not shown              
DA451268 tongue, tumor tissue Gene C6orf62, variant not shown       capped      
AI800189 ovary, tumor, 5 pooled (see description) Gene C6orf62, variant not shown              
DB141519 thymus Gene C6orf62, variant not shown       capped      
DB345401 thymus Gene C6orf62, variant not shown              
DB155823 thymus Gene C6orf62, variant not shown       capped      
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h-u, .i-u, .j Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI